Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

CEC levels may be a useful marker for predicting prostate cancer progression.

EMT and metabolic pathways help cancer cells resist treatment and spread.

GnRH treatment can reduce breast cancer cell invasion.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Matriptase imbalance contributes to cancer development and spread.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Saw palmetto extract may help treat brain tumors by blocking a specific growth signal and blood vessel formation.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Thicker melanomas and nodular types are more likely to spread to sentinel lymph nodes.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Pulsed electric field treatment may help the immune system fight liver tumors.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.